VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Oze, Tsugiko [1 ]
Hiramatsu, Naoki [1 ]
Yakushijin, Takayuki [1 ]
Doi, Yoshinori [2 ]
Ogawa, Hiroyuki [3 ]
Hagiwara, Hideki [4 ]
Mita, Eiji [5 ]
Kaneko, Akira [6 ]
Katayama, Kazuhiro [7 ]
Hijioka, Taizo [8 ]
Tamura, Shinji [9 ]
Yoshihara, Harumasa [10 ]
Inoue, Atsuo [11 ]
Imai, Yasuharu [12 ]
Hayashi, Eijirou [13 ]
Hosui, Atsushi [1 ]
Miyagi, Takuya [1 ]
Yoshida, Yuichi [1 ]
Tatsumi, Tomohide [1 ]
Kiso, Shinichi [1 ]
Kanto, Tatsuya [1 ]
Kasahara, Akinori [1 ]
Hayashi, Norio [4 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[2] Otemae Hosp, Osaka, Japan
[3] Nishinomiya Municipal Cent Hosp, Nishinomiya, Hyogo, Japan
[4] Kansai Rousai Hosp, Amagasaki, Hyogo, Japan
[5] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[6] NTT W Osaka Hosp, Osaka, Japan
[7] Natl Hosp Org Osaka Minami Med Ctr, Kawachi Nagano, Japan
[8] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[9] Minoh City Hosp, Mino, Japan
[10] Osaka Rosai Hosp, Sakai, Osaka, Japan
[11] Osaka Gen Med Ctr, Osaka, Japan
[12] Ikeda Municipal Hosp, Ikeda, Osaka, Japan
[13] Mutual Aid Assoc Publ Sch Teacher, Kinki Cent Hosp, Itami, Hyogo, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：852A / 853A
页数：2
相关论文
共 50 条
  • [1] Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (10) : 1593 - 1599
  • [2] ASSOCIATION OF IL28B GENE VARIATIONS WITH MATHEMATICAL MODELING OF VIRAL KINETICS IN CHRONIC HEPATITIS C PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Liu, Chen-Hua
    Liu, Chun-Jen
    Kao, Jia-Horng
    HEPATOLOGY, 2010, 52 (04) : 759A - 759A
  • [3] Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4
    Shiha, Gamal
    Samir, Waleed
    Seif, Seham
    El-Etreby, Shahira A.
    Abdel-Khalek, Ehab
    HEPATOLOGY, 2012, 56 : 1023A - 1023A
  • [4] Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
    Rivero-Juarez, Antonio
    Camacho Espejo, Angela
    Perez-Camacho, Ines
    Neukam, Karin
    Caruz, Antonio
    Antonio Mira, Jose
    Mesa, Pilar
    Garcia-Lazaro, Milagros
    Torre-Cisneros, Julian
    Antonio Pineda, Juan
    Rivero, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 202 - 205
  • [5] IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
    Chayama, Kazuaki
    Hayes, C. Nelson
    Abe, Hiromi
    Miki, Daiki
    Ochi, Hidenori
    Karino, Yoshiyasu
    Toyota, Joji
    Nakamura, Yusuke
    Kamatani, Naoyuki
    Sezaki, Hitomi
    Kobayashi, Mariko
    Akuta, Norio
    Suzuki, Fumitaka
    Kumada, Hiromitsu
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (01): : 84 - 93
  • [6] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Younossi, Zobair M.
    Birerdinc, Aybike
    Estep, Mike
    Stepanova, Maria
    Afendy, Arian
    Baranova, Ancha
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [7] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Zobair M Younossi
    Aybike Birerdinc
    Mike Estep
    Maria Stepanova
    Arian Afendy
    Ancha Baranova
    Journal of Translational Medicine, 10
  • [8] Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Itokawa, Norio
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Kobayashi, Tamaki
    Kanazawa, Hidenori
    Sakamoto, Choitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 51 - 56
  • [9] ASSOCIATION OF IL28B GENOTYPES WITH SERUM LIPID PROFILES AND EARLY VIRAL KINETICS IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Hsu, Ching-Sheng
    Liu, Chen-Hua
    Chen, Hung-Chia
    Hsu, Shih-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2011, 54 : 835A - 835A
  • [10] GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Kurosaki, M.
    Tanaka, Y.
    Nishida, N.
    Sugiyama, M.
    Matsuura, K.
    Asahina, Y.
    Sugauchi, F.
    Sakamoto, N.
    Nakagawa, M.
    Watanabe, M.
    Sakai, A.
    Honda, M.
    Kaneko, S.
    Ito, K.
    Masaki, N.
    Tokunaga, K.
    Izumi, N.
    Mizokami, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S451 - S452
12345